Looks like we will be waiting yet longer for Teva's generic epi. The FDA has found "major deficiencies" in Teva's application for an epinephrine auto-injector according to this Bloomberg article, Mylan's Epipen Boosted As FDA Sees Holes in Teva Application.
But there is always Windgap maybe...
And then, there is this intriguing news about a new patent for food allergy treatment. There's mention of combining the allergenic proteins with toothpaste--that's fascinating! Check it out: Intrammune Therapeutics Announces Issuance of U.S. Patent Covering Oral Mucuosal Immunotherapy for Food Allergy.
A lot going in the world of food allergies!